Job Reference Number: C2i123-RP3 The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the development of new vaccine and therapeutic strategies.   It is the fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur, Paris, two major international leaders combining their expertise to establish this centre of excellence.   C2i

Job Reference Number: C2i122-Admin The Centre for Immunology & Infection Limited (C2i) is a premier research institute focused on advancing biomarker discovery and the development of next-generation vaccines and therapeutic strategies. Founded through a strategic partnership of over 20 years between the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) and the Institut Pasteur in Paris, C2i integrates world-class expertise in biomedical science to drive innovat

Job Reference Number: C2i121-RP4 The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the development of new vaccine and therapeutic strategies.   It is the fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur, Paris, two major international leaders combining their expertise to establish this centre of excellence.   C2i

Job reference number: C2i120-RP1 Company Overview The Centre for Immunology & Infection (C2i) is a premier research institute focused on advancing biomarker discovery and the development of next-generation vaccines and therapeutic strategies. Founded through a strategic partnership of over 20 years between the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) and the Institut Pasteur in Paris, C2i integrates world-class expertise in biomedical science to drive

Job Reference Number: C2i119-RP2   The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the development of new vaccine and therapeutic strategies.   It is the fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur, Paris, two major international leaders combining their expertise to establish this centre of excellence. C2i

Job Reference Number: C2i118-RP4 The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the development of new vaccine and therapeutic strategies.   It is the fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur, Paris, two major international leaders combining their expertise to establish this centre of excellence.   C2i

The Centre for Immunology & Infection (C2i) is organising a Symposium as part of the 25 th  Anniversary of the HKU-Pasteur Research Pole week celebrating the long-lasting partnership between the University of Hong Kong (HKU) and the  Institut Pasteur .   The event will feature an overview of the past five years since the implementation of our center, highlighting key milestones and achievements. We will also discuss the next phase of development for C2i 2.0, which aims to enh

Professor   Michael Chan , Lead Scientist at C2i and CEO of C2iTech ,   was featured on RTHK's "Under the Sun" (太陽底下新鮮事) radio show, diving deep into the fascinating realm of organoid development! From lab breakthroughs to real-world impacts on medicine: https://www.rthk.hk/radio/radio1/programme/underthesun

We are delighted to share that C2iTech has been invited to attend the HKU Innovation Week 2025 and the TSSSU Ceremony! 🎉 As proud recipients for the 2024/2025 and 2025/2026 cycles, we look forward to showcasing our innovations and connecting with fellow leaders in technology and entrepreneurship. More info about the HKU Innovation Week: https://tec.hku.hk/innovation-week/ Join us as we drive the future of innovation!

The InnoHK Centre for Immunology & Infection Limited (C2i) and its spin-off C2iTech Limited have signed a Memorandum of Understanding (MOU) with Guangzhou Jingke Biotech Co., Ltd. and Shenzhen Jingke Biotech Co., Ltd. to advance patient-derived organoid (PDO) technologies for personalized oncology. The signing parties were represented by Professor Leo Poon , Managing Director, C2i; Professor Michael Chan , CEO, C2iTech; Mr. Sheng Li, Chairman, Jingke Biotech Group, and Profes

C2i is co-organizing a seminar with the HKUMed School of Public Health presented by  Professor Anna-Bella Failloux (Institut Pasteur,...

On the occasion of a joint seminar celebrating their partnership established in 2023, the Centre for Immunology & Infection Limited (C2i)...

08 May 2025 A research team led by the School of Public Health in the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in...

We are thrilled to report our remarkable achievements at the 50th   International Exhibition of Inventions Geneva 2025 . C2i showcased...

The Centre for Immunology & Infection and the HKU-Pasteur Research Pole share a new study in Nature Microbiology t hat explores the...

Job Reference Number: C2i061 The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the...

Job Reference Number: C2i040(A)P4 The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery...

A new milestone highlighting C2i's commitment to quality and excellence in research and services. The Centre for Immunology & Infection...

Jeong-eun Kim  and Eun-kyo Hong are two Master students from Andong National University (Republic of Korea)  who did a month-long...

A new publication in Eurosurveillance from Professor Leo Poon , Professor Malik Peiris , and teams at the Centre for Immunology &...